Now showing items 1-2 of 2

    • Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic 

      Kinyanjui, Peter; Wambui, Veronica; Kiptoo, Michael; Kinyua, Joyceline; Odera, Irene; Muge, Edward; Muiruri, Peter; Lihana, Raphael; Songok, Elijah M (2012)
      Background: CCR5 antagonists have clinically been approved for prevention or treatment of HIV/AIDS. Countries in Sub-Saharan Africa with the highest burden of HIV/AIDS are due to adopt these regimens. However, HIV-1 can ...
    • Predicted HIV-l coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic 

      Wambui, Veronica; Kiptoo, Michael; Kinyua, Joyceline; Odera, Irene; Muge, Edward; Muiruri, Peter; Lihana, Raphael; Kinyanjui, Peter; Songok, Elijah M (Department of Biochemistry, University of NairobiCentre for Virus Research, Kenya Medical Research Institute, Nairobi, 2012)
      Background: CCR5 antagonists have clinically been approved for prevention or treatment of HIVlAIDS. Countries in Sub-Saharan Africa with the highest burden of HIVlAIDS are due to adopt these regimens. However, HIV-l can ...